Skip to main navigation Skip to search Skip to main content

NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025

  • A. Dimitrios Colevas
  • , Anthony J. Cmelak
  • , David G. Pfister
  • , Sharon Spencer
  • , Douglas Adkins
  • , Andrew C. Birkeland
  • , David M. Brizel
  • , Paul M. Busse
  • , Jimmy J. Caudell
  • , Greg Durm
  • , Carole Fakhry
  • , Thomas Galloway
  • , Jessica L. Geiger
  • , Maura L. Gillison
  • , Christine Glastonbury
  • , Robert I. Haddad
  • , Wesley L. Hicks
  • , Ying J. Hitchcock
  • , Antonio Jimeno
  • , Aditya Juloori
  • Michael Kase, Debra Leizman, Ellie Maghami, Loren K. Mell, Bharat B. Mittal, Harlan A. Pinto, Katharine Price, James W. Rocco, Cristina P. Rodriguez, David Schwartz, Jatin P. Shah, David Sher, Maie St John, He Wang, Gregory Weinstein, Francis Worden, Justine Yang Bruce, Sue S. Yom, Weining Zhen, Sarah Montgomery, Susan D. Darlow
  • Stanford University
  • Vanderbilt University
  • Memorial Sloan-Kettering Cancer Center
  • University of Alabama at Birmingham
  • Washington University St. Louis
  • University of California at Davis
  • Duke University
  • Mass General Cancer Center
  • Moffitt Cancer Center
  • Indiana University Bloomington
  • Johns Hopkins University
  • Case Western Reserve University
  • University of Texas MD Anderson Cancer Center
  • University of California at San Francisco
  • Dana-Farber/Brigham and Women's Cancer Center
  • Roswell Park Comprehensive Cancer Center
  • University of Utah
  • University of Colorado Anschutz Medical Campus
  • UChicago Medicine Comprehensive Cancer Center
  • City of Hope National Medical Center
  • University of California at San Diego
  • Northwestern University
  • Mayo Clinic
  • Ohio State University
  • Fred Hutchinson Cancer Research Center
  • University of Tennessee Health Science Center
  • UT Southwestern Simmons Comprehensive Cancer Center
  • University of California at Los Angeles
  • Yale University
  • University of Pennsylvania
  • University of Michigan, Ann Arbor
  • University of Wisconsin-Madison
  • University of Nebraska Medical Center
  • National Comprehensive Cancer Network

Research output: Contribution to journal › Article › peer-review

158 Scopus citations

Abstract

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.

Original languageEnglish
Pages (from-to)2-11
Number of pages10
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume23
Issue number2
DOIs
StatePublished - Feb 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Education, Medical, Continuing
  • Head and Neck Neoplasms/therapy
  • Humans
  • Practice Guidelines as Topic

Fingerprint

Dive into the research topics of 'NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025'. Together they form a unique fingerprint.

Cite this